Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months
Clinical trial NCT04516967 · COMPLETED
Trial details
- NCT number
- NCT04516967
- Sponsor
- Sobi, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-05
- Primary completion
- 2023-11-08
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.